Global Breast Cancer Therapeutics Industry 2018 - Market Analysis, Overview, Size, Share, Trends, Production, Prospects, Segments and Forecasts to 2025

  • Get sample copy of the report

    This report focuses on the global Breast Cancer Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Therapeutics development in United States, Europe and China.
    
    Breast cancer is cancer that forms in the cells of the breasts.Breast cancer is cancer that develops from breast tissue. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. In those with distant spread of the disease, there may be bone pain, swollen lymph nodes, shortness of breath, or yellow skin.
    In 2017, the global Breast Cancer Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
    
    The key players covered in this study
        Bayer HealthCare
        Eli Lily
        Pfizer
        Novartis
        Eisai
        Halozyme Therapeutics
        Roche
        Puma Biotechnology
        Janssen Biotech
        AbbVie
        BioMarin
        Array BioPharma
        Merck
        Syndax
        MacroGenics
        ImmunoGen
        Santen Pharma
        Celgene
        Oncothyreon
        AstraZeneca
        Sprint Bioscience
        Genentech
        Galena Biopharma
        Lycera
        CTI BioPharma
    
    Market segment by Type, the product can be split into
        Mitotic Inhibitors
        Anti-Metabolites
        Hormone Receptor
        Aromatase Inhibitors
        HER2 Inhibitors
    
    Market segment by Application, split into
        Hospital
        Research
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Breast Cancer Therapeutics status, future forecast, growth opportunity, key market and key players.
        To present the Breast Cancer Therapeutics development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Breast Cancer Therapeutics are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Breast Cancer Therapeutics Market Size Growth Rate by Type (2013-2025)
            1.4.2 Mitotic Inhibitors
            1.4.3 Anti-Metabolites
            1.4.4 Hormone Receptor
            1.4.5 Aromatase Inhibitors
            1.4.6 HER2 Inhibitors
        1.5 Market by Application
            1.5.1 Global Breast Cancer Therapeutics Market Share by Application (2013-2025)
            1.5.2 Hospital
            1.5.3 Research
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Breast Cancer Therapeutics Market Size
        2.2 Breast Cancer Therapeutics Growth Trends by Regions
            2.2.1 Breast Cancer Therapeutics Market Size by Regions (2013-2025)
            2.2.2 Breast Cancer Therapeutics Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Breast Cancer Therapeutics Market Size by Manufacturers
            3.1.1 Global Breast Cancer Therapeutics Revenue by Manufacturers (2013-2018)
            3.1.2 Global Breast Cancer Therapeutics Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Breast Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.2 Breast Cancer Therapeutics Key Players Head office and Area Served
        3.3 Key Players Breast Cancer Therapeutics Product/Solution/Service
        3.4 Date of Enter into Breast Cancer Therapeutics Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Breast Cancer Therapeutics Market Size by Type (2013-2018)
        4.2 Global Breast Cancer Therapeutics Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Breast Cancer Therapeutics Market Size (2013-2018)
        5.2 Breast Cancer Therapeutics Key Players in United States
        5.3 United States Breast Cancer Therapeutics Market Size by Type
        5.4 United States Breast Cancer Therapeutics Market Size by Application
    
    6 Europe
        6.1 Europe Breast Cancer Therapeutics Market Size (2013-2018)
        6.2 Breast Cancer Therapeutics Key Players in Europe
        6.3 Europe Breast Cancer Therapeutics Market Size by Type
        6.4 Europe Breast Cancer Therapeutics Market Size by Application
    
    7 China
        7.1 China Breast Cancer Therapeutics Market Size (2013-2018)
        7.2 Breast Cancer Therapeutics Key Players in China
        7.3 China Breast Cancer Therapeutics Market Size by Type
        7.4 China Breast Cancer Therapeutics Market Size by Application
    
    8 Japan
        8.1 Japan Breast Cancer Therapeutics Market Size (2013-2018)
        8.2 Breast Cancer Therapeutics Key Players in Japan
        8.3 Japan Breast Cancer Therapeutics Market Size by Type
        8.4 Japan Breast Cancer Therapeutics Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Breast Cancer Therapeutics Market Size (2013-2018)
        9.2 Breast Cancer Therapeutics Key Players in Southeast Asia
        9.3 Southeast Asia Breast Cancer Therapeutics Market Size by Type
        9.4 Southeast Asia Breast Cancer Therapeutics Market Size by Application
    
    10 India
        10.1 India Breast Cancer Therapeutics Market Size (2013-2018)
        10.2 Breast Cancer Therapeutics Key Players in India
        10.3 India Breast Cancer Therapeutics Market Size by Type
        10.4 India Breast Cancer Therapeutics Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Breast Cancer Therapeutics Market Size (2013-2018)
        11.2 Breast Cancer Therapeutics Key Players in Central & South America
        11.3 Central & South America Breast Cancer Therapeutics Market Size by Type
        11.4 Central & South America Breast Cancer Therapeutics Market Size by Application
    
    12 International Players Profiles
        12.1 Bayer HealthCare
            12.1.1 Bayer HealthCare Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Breast Cancer Therapeutics Introduction
            12.1.4 Bayer HealthCare Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.1.5 Bayer HealthCare Recent Development
        12.2 Eli Lily
            12.2.1 Eli Lily Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Breast Cancer Therapeutics Introduction
            12.2.4 Eli Lily Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.2.5 Eli Lily Recent Development
        12.3 Pfizer
            12.3.1 Pfizer Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Breast Cancer Therapeutics Introduction
            12.3.4 Pfizer Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.3.5 Pfizer Recent Development
        12.4 Novartis
            12.4.1 Novartis Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Breast Cancer Therapeutics Introduction
            12.4.4 Novartis Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.4.5 Novartis Recent Development
        12.5 Eisai
            12.5.1 Eisai Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Breast Cancer Therapeutics Introduction
            12.5.4 Eisai Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.5.5 Eisai Recent Development
        12.6 Halozyme Therapeutics
            12.6.1 Halozyme Therapeutics Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Breast Cancer Therapeutics Introduction
            12.6.4 Halozyme Therapeutics Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.6.5 Halozyme Therapeutics Recent Development
        12.7 Roche
            12.7.1 Roche Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Breast Cancer Therapeutics Introduction
            12.7.4 Roche Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.7.5 Roche Recent Development
        12.8 Puma Biotechnology
            12.8.1 Puma Biotechnology Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Breast Cancer Therapeutics Introduction
            12.8.4 Puma Biotechnology Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.8.5 Puma Biotechnology Recent Development
        12.9 Janssen Biotech
            12.9.1 Janssen Biotech Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Breast Cancer Therapeutics Introduction
            12.9.4 Janssen Biotech Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.9.5 Janssen Biotech Recent Development
        12.10 AbbVie
            12.10.1 AbbVie Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Breast Cancer Therapeutics Introduction
            12.10.4 AbbVie Revenue in Breast Cancer Therapeutics Business (2013-2018)
            12.10.5 AbbVie Recent Development
        12.11 BioMarin
        12.12 Array BioPharma
        12.13 Merck
        12.14 Syndax
        12.15 MacroGenics
        12.16 ImmunoGen
        12.17 Santen Pharma
        12.18 Celgene
        12.19 Oncothyreon
        12.20 AstraZeneca
        12.21 Sprint Bioscience
        12.22 Genentech
        12.23 Galena Biopharma
        12.24 Lycera
        12.25 CTI BioPharma
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Breast Cancer Therapeutics Key Market Segments
        Table Key Players Breast Cancer Therapeutics Covered
        Table Global Breast Cancer Therapeutics Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Breast Cancer Therapeutics Market Size Market Share by Type 2013-2025
        Figure Mitotic Inhibitors Figures
        Table Key Players of Mitotic Inhibitors
        Figure Anti-Metabolites Figures
        Table Key Players of Anti-Metabolites
        Figure Hormone Receptor Figures
        Table Key Players of Hormone Receptor
        Figure Aromatase Inhibitors Figures
        Table Key Players of Aromatase Inhibitors
        Figure HER2 Inhibitors Figures
        Table Key Players of HER2 Inhibitors
        Table Global Breast Cancer Therapeutics Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospital Case Studies
        Figure Research Case Studies
        Figure Breast Cancer Therapeutics Report Years Considered
        Table Global Breast Cancer Therapeutics Market Size 2013-2025 (Million US$)
        Figure Global Breast Cancer Therapeutics Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Breast Cancer Therapeutics Market Size by Regions 2013-2025 (Million US$)
        Table Global Breast Cancer Therapeutics Market Size by Regions 2013-2018 (Million US$)
        Table Global Breast Cancer Therapeutics Market Share by Regions 2013-2018
        Figure Global Breast Cancer Therapeutics Market Share by Regions 2013-2018
        Figure Global Breast Cancer Therapeutics Market Share by Regions 2018
        Table Market Top Trends
        Table Global Breast Cancer Therapeutics Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Breast Cancer Therapeutics Market Share by Manufacturers (2013-2018)
        Figure Global Breast Cancer Therapeutics Market Share by Manufacturers in 2018
        Table Global Breast Cancer Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Breast Cancer Therapeutics Product/Solution/Service
        Table Date of Enter into Breast Cancer Therapeutics Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table Global Breast Cancer Therapeutics Market Size Share by Type (2013-2018)
        Figure Global Breast Cancer Therapeutics Market Size Market Share by Type (2013-2018)
        Table Global Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table Global Breast Cancer Therapeutics Market Size Share by Application (2013-2018)
        Figure Global Breast Cancer Therapeutics Market Size Market Share by Application (2013-2018)
        Figure Global Breast Cancer Therapeutics Revenue Market Share by Application in 2017
        Figure United States Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table United States Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table United States Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table United States Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table United States Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table United States Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table United States Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Figure Europe Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table Europe Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table Europe Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table Europe Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table Europe Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table Europe Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table Europe Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Figure China Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table China Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table China Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table China Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table China Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table China Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table China Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Figure Japan Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table Japan Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table Japan Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table Japan Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table Japan Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table Japan Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table Japan Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Figure Southeast Asia Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table Southeast Asia Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table Southeast Asia Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Figure India Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table India Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table India Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table India Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table India Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table India Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table India Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Figure Central & South America Breast Cancer Therapeutics Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Breast Cancer Therapeutics Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Breast Cancer Therapeutics Market Share (2017-2018)
        Table Central & South America Breast Cancer Therapeutics Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Breast Cancer Therapeutics Market Share by Type (2013-2018)
        Table Central & South America Breast Cancer Therapeutics Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Breast Cancer Therapeutics Market Share by Application (2013-2018)
        Table Bayer HealthCare Company Details
        Table Bayer HealthCare Revenue in Breast Cancer Therapeutics Business (2013-2018) (Million US$)
        Figure Bayer HealthCare Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Bayer HealthCare Recent Development
        Table Eli Lily Company Details
        Table Eli Lily Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Eli Lily Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Eli Lily Recent Development
        Table Pfizer Company Details
        Table Pfizer Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Pfizer Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Pfizer Recent Development
        Table Novartis Company Details
        Table Novartis Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Novartis Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Novartis Recent Development
        Table Eisai Company Details
        Table Eisai Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Eisai Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Eisai Recent Development
        Table Halozyme Therapeutics Company Details
        Table Halozyme Therapeutics Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Halozyme Therapeutics Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Halozyme Therapeutics Recent Development
        Table Roche Company Details
        Table Roche Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Roche Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Roche Recent Development
        Table Puma Biotechnology Company Details
        Table Puma Biotechnology Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Puma Biotechnology Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Puma Biotechnology Recent Development
        Table Janssen Biotech Company Details
        Table Janssen Biotech Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure Janssen Biotech Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table Janssen Biotech Recent Development
        Table AbbVie Company Details
        Table AbbVie Revenue in Breast Cancer Therapeutics Business (2013-2018)(Million US$)
        Figure AbbVie Revenue Growth Rate in Breast Cancer Therapeutics Business (2013-2018)
        Table AbbVie Recent Development
        Table BioMarin Company Details
        Table Array BioPharma Company Details
        Table Merck Company Details
        Table Syndax Company Details
        Table MacroGenics Company Details
        Table ImmunoGen Company Details
        Table Santen Pharma Company Details
        Table Celgene Company Details
        Table Oncothyreon Company Details
        Table AstraZeneca Company Details
        Table Sprint Bioscience Company Details
        Table Genentech Company Details
        Table Galena Biopharma Company Details
        Table Lycera Company Details
        Table CTI BioPharma Company Details
        Table Global Breast Cancer Therapeutics Market Size by Regions (Million US$) 2018-2025
        Figure Global Breast Cancer Therapeutics Market Size Share by Regions (2018-2025)
        Figure Global Breast Cancer Therapeutics Market Size Share by Regions in 2025
        Figure United States Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Figure China Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Figure India Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Breast Cancer Therapeutics Market Size Forecast (2018-2025)(Million USD)
        Table Global Breast Cancer Therapeutics Market Size by Product (2018-2025) (Million US$)
        Figure Global Breast Cancer Therapeutics Market Size by Product (2018-2025)
        Figure Global Breast Cancer Therapeutics Market Size by Product in 2025
        Table Global Breast Cancer Therapeutics Market Size by Application (2018-2025) (Million US$)
        Figure Global Breast Cancer Therapeutics Market Size by Application (2018-2025)
        Figure Global Breast Cancer Therapeutics Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources